Effects of extended-release niacin with laropiprant in high-risk patients

Martin J Landray, Richard Haynes, Jemma C Hopewell, Sarah Parish, Theingi Aung, Joseph Tomson, Karl Wallendszus, Martin Craig, Lixin Jiang, Rory Collins, Jane Armitage, HPS2-THRIVE Collaborative Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

911 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftThe New England Journal of Medicine
Vol/bind371
Udgave nummer3
Sider (fra-til)203-212
Antal sider10
ISSN0028-4793
DOI
StatusUdgivet - 17 jul. 2014

Fingeraftryk Dyk ned i forskningsemnerne om 'Effects of extended-release niacin with laropiprant in high-risk patients'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Landray, M. J., Haynes, R., Hopewell, J. C., Parish, S., Aung, T., Tomson, J., Wallendszus, K., Craig, M., Jiang, L., Collins, R., Armitage, J., & HPS2-THRIVE Collaborative Group (2014). Effects of extended-release niacin with laropiprant in high-risk patients. The New England Journal of Medicine, 371(3), 203-212. https://doi.org/10.1056/NEJMoa1300955